deaths from tirzepatide Weight-loss drug may lower heart failure SUMMIT: Tirzepatide a 'Huge Win'

Gastrointestinal Effects The most frequently reported adverse reactions with semaglutide include: Nausea (occurring in 15-44% of patients depending on dose and indication) Vomiting (5-24% of patients) Diarrhea (8-30% of patients) Constipation (11-24% of patients) Abdominal pain (5-20% of patients) These symptoms typically emerge during dose escalation and often improve over time

A decision-making theory of visual detection

Roager HM, Licht TR

(2021) investigated the primary tumor tissues collected from patients with T4Nx colorectal cancer, and they determined that CPT1A was downregulated in patients with peritoneal metastases

To view or add a comment, sign in More Relevant Posts I was pleased to speak with Hartford Business Journal recently about a topic that continues to be a key focus for Connecticut employers: GLP-1 medications

Client notice the results in all the IV drips